Procter & Gamble Health Ltd. Share Price

Overview

Procter & Gamble Health Ltd. share price is currently ₹5,111.18, down by - ₹28.82 (0.56%) from its previous closing price of ₹5,140.00. The share price has declined -7.6% over the past month and declined -17.36% over the past year. The stock's 52-week low and high are ₹4,666.22 and ₹6,902.46, respectively. Procter & Gamble Health Ltd. has a market capitalisation of ₹ 8,900.00 Cr. The share price was last updated on 09 Oct 2026, 03:53 PM IST.

Procter & Gamble Health Ltd.
Procter & Gamble Health Ltd.
PGHL
 ₹0.00
- ₹28.82
0.56%
Healthcare
 ₹0.00(%)1D

Updated: 09 Oct 2026, 03:53:42 pm IST

Market Data

Open Price

 ₹5,077.42

Prev. Close

 ₹5,140.00
 ₹5,019.21

Day Low

 ₹5,182.63

Day High

 ₹4,666.22

52 Week Low

 ₹6,902.46

52 Week High

HealthcarePharmaceuticals & Drugs
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

23.77

Sector PE

43.59

PB Ratio

16.33

Sector PB

5.76

EPS

214.99

Dividend Yield

4.27

Today's Volume

7.416 K

5 Day Avg. Volume

10.224 K

PEG Ratio

0.60

Market Cap.

₹ 8,900.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 450% at ₹45/Share
27-Aug-202627-Aug-2026
DividendsSpecial Dividend of 500% at ₹50/Share
12-Feb-202612-Feb-2026
DividendsInterim Dividend of 1100% at ₹110/Share
12-Feb-202612-Feb-2026
DividendsFinal Dividend of 450% at ₹45/Share
22-Aug-202522-Aug-2025

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
UTI MNC Fund - Regular Plan - IDCW1.90 Lac
1.90 Lac
no change
Aditya Birla Sun Life MNC Fund - Regular Plan - Growth94.72 k
94.72 k
no change
UTI Healthcare Fund - Regular Plan - IDCW50.00 k
50.00 k
no change
Aditya Birla Sun Life Consumption Fund - Regular Plan - Growth44.50 k
44.50 k
no change
Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth35.20 k
35.20 k
no change

About Procter & Gamble Health Ltd. 👋

Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. The Company operates through two segments: Pharmaceuticals and Chemicals. Its geographical segments include Domestic and Exports. Its Pharmaceutical segment consists of ethicals used in the treatment of cardiovascular and metabolic diseases, consumer healthcare products and vitamins-based formulations. The Pharmaceuticals segment has two business divisions: BioPharma and Consumer Health. Its Chemicals segment includes bulk drugs and pigments. It consists of two divisions: Pharma Chem Solutions and Performance Materials. The Pharm Chem Solutions division offers products and solutions, including active pharmaceutical ingredients, excipients. It offers products, such as vitamin E, guaizulene, thaiminedisulphide (TDS).

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Harsh Vardhan

Harsh Vardhan

31 Aug • 3:10 PM · SEBI-Registered Analyst

P&G Hygiene: Premium Brands & Strong Dividends

PGHL
Procter & Gamble Hygiene & Health Care (PGHH) has a strong portfolio in feminine hygiene, healthcare and personal care, led by brands such as Whisper and Vicks. FY26 net profit rose 34.5%, while Q4 revenue declined 5.1% YoY and net profit fell about 2% to ₹153 crore, reflecting near-term demand and cost pressures. Latest News: The company continues to focus on premiumisation, innovation and strengthening its core brands. P&G globally expects FY27 sales growth of 1–3%, with higher input and marketing costs remaining a concern. Corporate Action: PGHH declared a ₹60/share final dividend for FY26. Earlier, it paid an interim ₹195/share, including a ₹25 special dividend. Strong brands, pricing power and exceptional dividend payouts support the long-term case, while premium valuation, weak volume growth and input-cost inflation remain key risks.

See More
Sohrab Shaikh (SEBI RA)

Sohrab Shaikh (SEBI RA)

22 Aug • 10:34 PM · SEBI-Registered Analyst

Stocks having high delivery quantity as on 22.08.2025

1. Karur Vysya Bank 2. PGHL 3. Netweb Technologies India 4. PTC Industries 5. JB Chemicals 6. ABFRL 7. Zen Technologies

KARURVYSYA

See More
Sohrab Shaikh (SEBI RA)

Sohrab Shaikh (SEBI RA)

21 Aug • 7:02 PM · SEBI-Registered Analyst

Companies having ex dividend on 22.08.205

1. ABM Knowledgeware Rs. 1.25 per share 2. AK Capital Services Rs. 14 per share 3. APL Apollo Tubes Rs. 5.75 per share 4. ASM Technologies Rs. 1 per share 5. Bannari Amman Sugars Rs. 12.5 per share 6. Deep Industries Rs. 3.05 per share 7. DAPS Advertising Rs. 0.2 per share 8. eClerx Services Rs. 1 per share 9. Gujarat Ambuja Exports Rs. 0.25 per share 10. IRCTC Rs. 1 per share 11. Jindal Stainless Rs. 2 per share 12. Jindal Steel Rs. 2 per share 13. KFin Technologies Rs. 7.5 pe share 14. LIC Housing Finance Rs. 10 per share 15. Lodha Developers Rs. 4.25 pe share 16. Netweb Technologies Rs. 2.5 per share 17. Procter & Gamble Health Rs. 45 per share 18. The Federal Bank Rs. 1.2 per share

IRCTC

See More
Vineet Chawla

Vineet Chawla

1 Aug • 11:38 PM · SEBI-Registered Analyst

close crossing 52 week high

PGHL
- New 52-Week High: Reached a new milestone in its upward journey. - Price Appreciation: Notable increase in stock price. - Strong Bullish Trend: Robust upward momentum driven by positive market sentiment. - Increased Investor Confidence: Investors are becoming more confident in the company's prospects. - Positive Market Sentiment: Overall positive sentiment contributing to upward momentum. Disclaimer: Investing and Trading in Stock Market is risky activity. Always trade with a stop loss. Do not Trade's invest by taking loan and trade only with the money that you can afford to risk. Do not put your entire capital in one single Trade.

See More
Akshay Patel

Akshay Patel

30 May • 10:40 AM · SEBI-Registered Analyst

P&G Health Q4 updates

PGHL
numbers from Q4 announcement - Revenue at ₹311 crore versus ₹252.2 crore, up 23.2% Net profit at ₹61.18 crore versus ₹46.56 crore, up 31.3% EBITDA at ₹81 crore versus ₹67.5 crore, up 20.2% Margin at 26.08% versus 26.73%

See More
SASI KUMAR SEBI RA

SASI KUMAR SEBI RA

30 May • 8:13 AM · SEBI-Registered Analyst

Stock Market Update & Stocks to watch today – 30th May, 2025

Here’s a simple look at key stocks and news to watch today: In Focus Today: • Bajaj Auto: Profit up 6% YoY. Revenue and margins also improved. • Ipca Labs: Strong Q4 – Profit up 13.8%, margin jumps to 19.09%. • Mazagon Dock: Profit dropped 51%, but revenue up slightly. ₹2.71 final dividend declared. • Lemon Tree Hotels: Profit up 26%, revenue up 15.6%. • Suzlon Energy: Huge jump – Profit up 365%, strong revenue growth. • NBCC: Profit up 29%, revenue up 16%. • Ola Electric: Loss doubled, revenue fell by 62%. • Sobha: Profit up 481%, revenue up 63%. ₹3 dividend declared. Other Earnings Highlights: • Procter & Gamble Health: Profit up 31%. • Amara Raja: Profit fell 30%, ₹5.20 dividend. • Gujarat Pipavav Port: Profit up 71%, ₹4.20 dividend. • ICRA: Profit up 19%, ₹60 dividend. • SJVN: Reports a loss of ₹127.7 crore. Big Developments: • NLC India (subsidiary) ties up with MAHAPREIT to build 2,000 MW renewable energy in Maharashtra. Bulk & Block Deals: • Harsha Engineers: DSP MF buys 4.64 lakh shares @ ₹383. • IFB Agro: Pinewood Fund buys 50,000 shares @ ₹688. • IndiGo: BNP Paribas buys 46,000 shares @ ₹5,246.35 from Morgan Stanley. Stocks Going Ex-Dividend Today: Infosys, Bajaj Finance, Angel One, GSK Pharma, Minda, and others. Watch out for earnings trends, dividends, and large investor movements — they often signal stock momentum.

See More

Frequently Asked Questions

What is the share price of Procter & Gamble Health Ltd.?

What is the market cap of Procter & Gamble Health Ltd.?

Should I buy Procter & Gamble Health Ltd. stock now?

What is the 52 week high and low of Procter & Gamble Health Ltd.?

Is the Procter & Gamble Health Ltd. stock good to buy?

Is Procter & Gamble Health Ltd. a good buy for the long term?

Is Procter & Gamble Health Ltd. overvalued or undervalued?

What is the PE and PB ratio of Procter & Gamble Health Ltd.?

Start Now